Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinomaXingming Zhang, Hao Zeng|BMC Cancer|2019Cited by 25
Efficacy of Second-Line ICIs Combined with TKIs among Patients with Metastatic Renal Cell Carcinoma: A Real-World StudyHaoran Zhang, Pengfei Shen, Junru Chen et al.|Immunotherapy|2022Cited by 2